4

OWNERSHIP DOCUMENT

Company: Matinas BioPharma Holdings, Inc.
Filed: May 2, 2018
Period of Report: April 30, 2018
Accession Number: 0000905718-18-000450

View Document ↗ View on SEC.gov ↗